Causes and Treatment Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 82 Adult Patients
Hye-In Kim, Shin-Woo Kim, Ga-Young Park, Eu-Gene Kwon, Hyo-Hoon Kim, Ju-Young Jeong, Hyun-Ha Chang, Jong-Myung Lee, Neung-Su Kim
Korean J Intern Med. 2012;27(2):203-210.   Published online 2012 May 31     DOI: https://doi.org/10.3904/kjim.2012.27.2.203
Citations to this article as recorded by Crossref logo
Update on Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Diagnosis and Management
Hemali Shah, Rose Parisi, Eric Mukherjee, Elizabeth J. Phillips, Roni P. Dodiuk-Gad
American Journal of Clinical Dermatology.2024; 25(6): 891.     CrossRef
Systematic review and meta‐analysis of non‐SCORTEN predictors of mortality in Stevens‐Johnson syndrome and toxic epidermal necrolysis
Thomas Jonathan Stewart, Hemali Shah, John Frew
International Journal of Dermatology.2024;[Epub]     CrossRef
Infectious complications of Stevens‐Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta‐analysis
Thomas Jonathan Stewart, Chon‐Wai Jeremy Chan, Hemali Shah, John Frew
International Journal of Dermatology.2024;[Epub]     CrossRef
Serum levels of C‐C motif chemokine ligand 2 and interleukin‐8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome
Tomoya Watanabe, Yuko Watanabe, Noriko Ikeda, Michiko Aihara, Yukie Yamaguchi
The Journal of Dermatology.2023; 50(4): 500.     CrossRef
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Erika Yue Lee, Christopher Knox, Elizabeth Jane Phillips
JAMA Dermatology.2023; 159(4): 384.     CrossRef
APOA4 as a novel predictor of prognosis in Stevens-Johnson syndrome/toxic epidermal necrolysis: A proteomics analysis from two prospective cohorts
Ting Gong, Peng Zhang, Shi-Fan Ruan, Zhixun Xiao, Wen Chen, Min Lin, Qingmei Zhong, Renwei Luo, Qiuyun Xu, Jiamei Peng, Bo Cheng, Fa Chen, Lihong Chen, Wen-Hung Chung, Chao Ji
Journal of the American Academy of Dermatology.2023; 89(1): 45.     CrossRef
Stevens – Johnson syndrome: a case report
N. S. Iamkina, V. V. Boyarko, E. V. Bukreeva
The Siberian Journal of Clinical and Experimental Medicine.2023; 38(2): 248.     CrossRef
Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
Kevin Phan, Lawrence J. Oh, Andrea Issler-Fisher, Amshuman Rao, Eugene H. Wong, Peter Maitz
Journal of Dermatological Treatment.2022; 33(1): 525.     CrossRef
A Rare Pediatric Case of Cefixime Induced Toxic Epidermal Necrolysis
Tirin Babu, George Mathew Panachiyil, Prajwala Hassan Vasudev, Mandyam Dhati Ravi
Hospital Pharmacy.2022; 57(2): 237.     CrossRef
Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis - A retrospective study in a tertiary hospital in South India
Thanuja Gopal Pradeep, Samyakta A. Shetti
Taiwan Journal of Ophthalmology.2022; 12(2): 184.     CrossRef
Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China
Lu Yang, Yan-Hong Shou, Feng Li, Xiao-Hua Zhu, Yong-Sheng Yang, Jin-Hua Xu
Frontiers in Pharmacology.2022;[Epub]     CrossRef
Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study
Jing Zhang, Chun-Wei Lu, Chun-Bing Chen, Chuang-Wei Wang, Wei-Ti Chen, Bo Cheng, Chao Ji, Wen-Hung Chung
The Journal of Allergy and Clinical Immunology: In Practice.2022; 10(5): 1295.     CrossRef
Colistin-associated Stevens-Johnson syndrome and toxic epidermal necrolysis reactions: a retrospective case-non-case pharmacovigilance study
Richard Tang, Vrishali L. Lopes, Aisling R. Caffrey
Expert Opinion on Drug Safety.2022; 21(8): 1121.     CrossRef
Undiagnosed and Rare Diseases in Critical Care
Bridget E. Shields, Karolyn A. Wanat, Yvonne E. Chiu
Critical Care Clinics.2022; 38(2): 243.     CrossRef
A Retrospective Study into Causes and Treatments of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Iranian Patients
S. Zareei, S. H. Nabavizadeh, N. Zareei, R. Abbasi
Journal of Clinical Care and Skills.2022; 3(1): 19.     CrossRef
Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients
Tomoya Watanabe, Hirofumi Go, Yusuke Saigusa, Naoko Takamura, Yuko Watanabe, Yumiko Yamane, Michiru Totsuka, Hideyuki Ishikawa, Kazuko Nakamura, Setsuko Matsukura, Takeshi Kambara, Shunsuke Takaki, Yukie Yamaguchi, Michiko Aihara
Allergology International.2021; 70(2): 229.     CrossRef
Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis
Israa Alfares, Muhammad Shahid Javaid, Zhibin Chen, Alison Anderson, Ana Antonic-Baker, Patrick Kwan
CNS Drugs.2021; 35(2): 161.     CrossRef
Viral Infections and Cutaneous Drug-Related Eruptions
Eleonora Anci, Camille Braun, Annalisa Marinosci, Frédérique Rodieux, Elise Midun, Maria-Jose Torres, Jean-Christoph Caubet
Frontiers in Pharmacology.2021;[Epub]     CrossRef
Diagnostic and Treatment Approach in the Management of Dental Anomalies Associated with Stevens–Johnson Syndrome: A Case Report
Sakshi Katyal, Vijay Yadav
International Journal of Clinical Pediatric Dentistry.2021; 14(4): 569.     CrossRef
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults
Lucia Seminario-Vidal, Daniela Kroshinsky, Stephen J. Malachowski, James Sun, Alina Markova, Thomas M. Beachkofsky, Benjamin H. Kaffenberger, Elizabeth N. Ergen, Melissa Mauskar, Alina Bridges, Cody Calhoun, Adela R. Cardones, Steven T. Chen, James Chodos
Journal of the American Academy of Dermatology.2020; 82(6): 1553.     CrossRef
A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis
James W. Antoon, Jennifer L. Goldman, Samir S. Shah, Brian Lee
The Journal of Allergy and Clinical Immunology: In Practice.2019; 7(1): 244.     CrossRef
Lip synechiae: A rare complication of azithromycin-associated Stevens–Johnson syndrome
Madan Mishra, Gaurav Singh, Amit Gaur, Abhivyakti Tewari
National Journal of Maxillofacial Surgery.2019; 10(2): 232.     CrossRef
A Case Report—Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine
Priyanka Jadhav, Jane E. Rogers, Rachna Shroff
Journal of Gastrointestinal Cancer.2018; 49(3): 349.     CrossRef
Chronic ocular complications of Stevens-Johnson syndrome associated with causative medications in Korea
Hyo Kyung Lee, Kyung Chul Yoon, Kyoung Yul Seo, Mayumi Ueta, Mee Kum Kim
The Journal of Allergy and Clinical Immunology: In Practice.2018; 6(2): 700.     CrossRef
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr
Clinical Reviews in Allergy & Immunology.2018; 54(1): 147.     CrossRef
The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
Shang-Chen Yang, Sindy Hu, Sheng-Zheng Zhang, Jin-wen Huang, Jing Zhang, Chao Ji, Bo Cheng
Journal of Immunology Research.2018; 2018: 1.     CrossRef
Clinical Features and Treatment Outcomes among Children with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A 20-Year Study in a Tertiary Referral Hospital
Susheera Chatproedprai, Vanvara Wutticharoenwong, Therdpong Tempark, Siriwan Wananukul
Dermatology Research and Practice.2018; 2018: 1.     CrossRef
Toxic epidermal necrolysis data from the CELESTE multinational registry. Part I: Epidemiology and general microbiological characteristics
B. Lipový, J. Holoubek, M. Hanslianová, M. Cvanová, L. Klein, I. Grossová, R. Zajíček, P. Bukovčan, J. Koller, M. Baran, P. Lengyel, L. Eimer, M. Jandová, M. Košťál, P. Brychta
Burns.2018; 44(6): 1551.     CrossRef
DILI Associated with Skin Reactions
Sahand Rahnama-Moghadam, Hans L. Tillmann
Current Hepatology Reports.2018; 17(3): 225.     CrossRef
Experience of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Regional Hospital: 70 Cases in 7 Years
Jaechun Lee, Jae Wang Kim
The Korean Journal of Medicine.2017; 92(2): 171.     CrossRef
Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients
Li Wang, Xue-Ling Mei
Chinese Medical Journal.2017; 130(9): 1062.     CrossRef
Stevens-Johnson syndrome and toxic epidermal necrolysis in Dr. Hasan Sadikin General Hospital Bandung, Indonesia from 2009-2013
Oki Suwarsa, Wulan Yuwita, Hartati Purbo Dharmadji, Endang Sutedja
Asia Pacific Allergy.2016; 6(1): 43.     CrossRef
Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
Derek Y. Hsu, Joaquin Brieva, Nanette B. Silverberg, Jonathan I. Silverberg
Journal of Investigative Dermatology.2016; 136(7): 1387.     CrossRef
Recurrent Toxic Epidermal Necrolysis Syndrome: A Report of Two Cases
Claudia Reynoso-von Drateln, Noemí Gómez-Hernández, Norma Rodríguez-Martínez, Carlos Torres-Lozano
Drug Safety - Case Reports.2016;[Epub]     CrossRef
The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens–Johnson Syndrome
Dong Hyun Kim, Kyung Chul Yoon, Kyoung Yul Seo, Hyo Seok Lee, Sang Chul Yoon, Chie Sotozono, Mayumi Ueta, Mee Kum Kim
Ophthalmology.2015; 122(2): 254.     CrossRef
Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine
Hye Jung Park, Sung Ryeol Kim, Dong Woo Leem, Il Joo Moon, Beom Seok Koh, Kyung Hee Park, Jung-Won Park, Jae-Hyun Lee
European Journal of Clinical Pharmacology.2015; 71(1): 35.     CrossRef
Stevens–Johnson syndrome and toxic epidermal necrolysis: a 20‐year single‐center experience
Jovan Lalosevic, Milos Nikolic, Mirjana Gajic‐Veljic, Dusan Skiljevic, Ljiljana Medenica
International Journal of Dermatology.2015; 54(8): 978.     CrossRef
Stevens–Johnson syndrome following cataract surgery
Shin-Hua Wu, Jen-Hsiang Shen, Wei-Hsiu Hsu, Chin-Wen Lin, Li-Ju Lai
Taiwan Journal of Ophthalmology.2015; 5(2): 96.     CrossRef
A novel therapeutic strategy for mycoplasma infectious diseases
Kazuhiro Matsuda
Personalized Medicine Universe.2015; 4: 32.     CrossRef
Corticosteroids in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Ernest H. Law, May Leung
Annals of Pharmacotherapy.2015; 49(3): 335.     CrossRef
Therapeutic Apheresis in Dermatological Diseases
Rolf Bambauer, Daniel Burgard, Ralf Schiel
Clinical Medicine Insights: Therapeutics.2015;[Epub]     CrossRef
Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok
Wanjarus Roongpisuthipong, Sirikarn Prompongsa, Theerawut Klangjareonchai
Dermatology Research and Practice.2014; 2014: 1.     CrossRef
NSAID Single-Drug–Induced Reactions
Katharine M. Woessner, Mariana Castells
Immunology and Allergy Clinics of North America.2013; 33(2): 237.     CrossRef
Rapidly Developing Toxic Epidermal Necrolysis
Viktoria Oline Barrios Poulsen, Jonas Nielsen, Troels Dirch Poulsen
Case Reports in Emergency Medicine.2013; 2013: 1.     CrossRef
Chronic pulmonary complications due to toxic epidermal necrolysis
Sun Hye Hwang, Dong Hyun Kim, Jeong Hee Kim, Byong Kwan Son, Dae Hyun Lim
Allergy, Asthma & Respiratory Disease.2013; 1(4): 391.     CrossRef
Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
Bernard Yu-Hor Thong
Asia Pacific Allergy.2013; 3(4): 215.     CrossRef